Effects of Chinese herbal medicine Ningdong Granule on regulating dopamine (DA)/serotonin (5-TH) and gamma-amino butyric acid (GABA) in patients with Tourette syndrome

BioScience Trends

Volumn 6, Issue 4, 2012, Pages 212-218

  Wang, Shuzhen ^a   Qi, Fanghua ^a   Li, Jijun ^b   Zhao, Lin ^a   Li, Anyuan ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Gamma amino butyric acid (GABA); Gilles de la Tourette Syndrome (TS); Ningdong granule (NDG), dopamine (DA); Serotonin (5 TH)

Indexed keywords

4 AMINOBUTYRIC ACID; 5 HYDROXYINDOLEACETIC ACID; DOPAMINE; HERBACEOUS AGENT; HOMOVANILLIC ACID; NINGDONG; SEROTONIN;

ADOLESCENT; ARTICLE; BLOOD; CHILD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GILLES DE LA TOURETTE SYNDROME; HUMAN; KIDNEY FUNCTION TEST; LIVER FUNCTION TEST; MALE; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; TIC;

ADOLESCENT; CHILD; DOPAMINE; DRUGS, CHINESE HERBAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GAMMA-AMINOBUTYRIC ACID; HOMOVANILLIC ACID; HUMANS; HYDROXYINDOLEACETIC ACID; KIDNEY FUNCTION TESTS; LIVER FUNCTION TESTS; MALE; SEROTONIN; TICS; TOURETTE SYNDROME;

ANIMALIA; RATTUS;

EID: 84866845606     PISSN: 18817815     EISSN: 18817823     Source Type: Journal    
DOI: 10.5582/bst.2012.v6.4.212     Document Type: Article

References (39)

1. Du JC, Chiu TF, Lee KM, Wu HL, Yang YC, Hsu SY, Sun CS, Hwang B, Leckman JF. Tourette syndrome in children: An updated review. Pediatr Neonatol. 2010; 51:255-264.
2. Cortese S, Lecendreux M, Bernardo BD, Mouren MC, Sbarbati A, Konofal E. Attention-deficit/hyperactivity disorder, Tourette's syndrome, and restless legs syndrome: The iron hypothesis. Medical Hypotheses. 2008; 70:1128-1132.
3. Grimaldi BL. The central role of magnesium deficiency in Tourette's syndrome: Causal relationships between magnesium deficiency, altered biochemical pathways and symptoms relating to Tourette's syndrome and several reported comorbid conditions. Med Hypotheses. 2002; 58:47-60.
4. Peterson BS, Leckman JF. The temporal dynamics of tics in Gilles de la Tourette syndrome. Biol Psychiatry. 1998; 44:1337-1348.
5. Oades RD. Differential measures of 'sustained attention' in children with attention-deficit hyperactivity or tic disorders: Relations to monoamine metabolism. Psychiatry Res. 2000; 93:165-178.
6. Tian Y, Gunther JR, Liao IH, Liu D, Ander BP, Stamova BS, Lit L, Jickling GC, Xu H, Zhan X, Sharp FR.GABA- and acetylcholine-related gene expression in blood correlate with tic severity and microarray evidence for alternative splicing in Tourette syndrome: A pilot study. Brain Res. 2011; 228-236.
7. Fachinetto R, Villarinho JG, Wagner C, Pereira RP, Avila DS, Burger ME, Calixto JB, Rocha JB, Ferreira J. Valeriana officinalis does not alter the orofacial dyskinesia induced by haloperidol in rats: Role of dopamine transporter. Prog Neuropsychopharmacol Biol Psychiatry. 2007; 31:1478-1486.
8. Yoo HK, Kim JY, Kim CY. A pilot study of aripiprazole in children and adolescents with Tourette's disorder. J Child Adolesc Psychopharmacol. 2006; 16:505-506.
9. Cui XY, Wang YL, Kokudo N, Fang DZ, Tang W. Traditional Chinese medicine and related active compounds against hepatitis B virus infection. Biosci Trends. 2010; 4:39-47.
10. Baeza I, Castro-Fornieles J, Deulofeu R, de la Serna E, Goti J, Salva J, Bernardo M. Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients. Psychiatry Res. 2009; 168:110-118.
11. Qi FH, Li AY, Inagaki Y, Gao JJ, Li JJ, Kokudo N, Li XK, Tang W. Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer. Biosci Trends. 2010; 4:297-307.
12. Zhao L, Li AY, Lv H, Liu FY, Qi FH. Traditional Chinese medicine Ningdong granule: The beneficial effects in Tourette's disorder. J Int Med Res. 2010; 38:169-175.
13. Lv H, Li A, Ma H, Liu F, Xu H. Effects of Ningdong granule on the dopamine system of Tourette's syndrome rat models. J Ethnopharmacol. 2009; 124:488-492.
14. Li JJ, Li ZW, Wang SZ, Qi FH; Zhao L, Lv H, Li AY. Ningdong granule: A complementary and alternative therapy in the treatment of attention deficit/hyperactivity disorder. Psychopharmacology. 2011; 216:501-509.
15. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th ed. (DSMIV). American Psychiatric Association, Washington, DC, USA.
16. Shapiro E, Shapiro AK, Fulop G, Hubbard M, Mandeli J, Nordlie J, Phillips RA. Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry. 1989; 46:722-730.
17. Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, Cohen DJ. The Yale Global Tic Severity Scale: Initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry. 1989; 28:566-573.
18. Wong DF, Brasic JR, Singer HS, Schretlen DJ, Kuwabara H, Zhou Y, Nandi A, Maris MA, Alexander M, Ye W, Rousset O, Kumar A, Szabo Z, Gjedde A, Grace AA. Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: Clues from an in vivo neurochemistry study with PET. Neuropsychopharmacology. 2008; 33:1239-1251.
19. Albin RL, Mink JW. Recent advances in Tourette syndrome research. Trends Neurosci. 2006; 29:175-182.
20. Jimenez-Shahed J. Tourette syndrome. Neurol Clin. 2009; 27:737-755.
21. Müller-Vahl KR, Meyer GJ, Knapp WH, Emrich HM, Gielow P, Brücke T, Berding G. Serotonin transporter binding in Tourette Syndrome. Neurosci Lett. 2005; 385:120-125.
22. Seo D, Patrick CJ, Kennealy PJ. Role of Serotonin and Dopamine System Interactions in the Neurobiology of Impulsive Aggression and its Comorbidity with other Clinical Disorders. Aggress Violent Behav. 2008; 13:383-395.
23. Grados MA, Walkup JT. A new gene for Tourette's syndrome: A window into causal mechanisms. Trends Genet. 2006; 22:291-293.
24. Nieoullon A. Dopamine and the regulation of cognition and attention. Prog Neurobiol. 2002; 67:53-83.
25. Bohnen NI, Cham R. Postural control, gait, and dopamine functions in parkinsonian movement disorders. Clin Geriatr Med. 2006; 22:797-812.
26. Nutt D, Demyttenaere K, Janka Z, Aarre T, Bourin M, Canonico PL, Carrasco JL, Stahl S. The other face of depression reduced positive affect: The role of catecholamines in causation and cure. J Psychopharmacol. 2007; 21:461-471.
27. Staller JA, Faraone SV. Targeting the dopamine system in the treatment of attention-deficit/hyperactivity disorder. Expert Rev Neurother. 2007; 7:351-362.
28. Brooks DJ. Dopaminergic action beyond its effects on motor function: Imaging studies. J Neurol. 2006; 253: IV8-IV15.
29. Singer HS. Tourette's syndrome: From behavior to biology. Lancet Neurol. 2005; 4:149-159.
30. Baeza I, Castro-Fornieles J, Deulofeu R, de la Serna E, Goti J, Salva J, Bernardo M. Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients. Psychiatry Res. 2009; 168:110-118.
31. Dhir A, Kulkarni SK. Involvement of dopamine (DA)/ serotonin (5-HT)/sigma (sigma) receptor modulationin mediating the antidepressant action of ropinirole hydrochloride, a D2/D3 dopamine receptor agonist. Brain Res Bull. 2007; 74:58-65.
32. Soderstrom H, Blennow K, Sjodin AK, Forsman A. New evidence for an association between the CSF HVA/5- HIAA ratio and psychopathic traits. J Neurol Neurosurg Psychiatry. 2003; 74:918-921.
33. Daw N D, Kakade S, Dayan P. Opponent interactions between serotonin and dopamine. Neural Network. 2002; 15:603-616.
34. Yan, Z. Regulation of GABAergic inhibition by serotonin signaling in prefrontal cortex: Molecular mechanisms and functional implications. Mol Neurobiol. 2002; 26:203-216.
35. Davidson RJ, Putnam KM, Larson CL. Dysfunction in the neural circuitry of emotion regulation-A possible prelude to violence. Science.2000; 289:591-594.
36. Volavka, J. The neurobiology of violence: An update. J Neuropsychiatry Clin Neurosci. 1999; 11:307-314.
37. Anderson SA, Eisenstat DD, Shi L, Rubenstein JL. Interneuron migration from basal forebrain to neocortex: dependence on Dlx genes. Science. 1997; 278:474-476.
38. Ziemann U, Paulus W, Rothenberger A. Decreased motor inhibition in Tourette's disorder: Evidence from transcranial magnetic stimulation. Am J Psychiatry. 1997; 154:1277-1284.
39. Martino D, Dale RC, Gilbert DL, Giovannoni G, Leckman JF. Mov Disord. Immunopathogenic mechanisms in tourette syndrome: A critical review. Mov Disord. 2009; 24:1267-1279.